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The Crystal Structures of EDA-A1 and EDA-A2:
Splice Variants with Distinct Receptor Specificity
tity with EDAR in their extracellular regions. Unlike some
subgroups of the TNFL family, such as BAFF and APRIL,
LT and TNF, or FasL, LIGHT, and TL1A (Bodmer et al.,
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Vishva M. Dixit,2 Melissa A. Starovasnik,1
2002; Migone et al., 2002), in which either the ligandsand Abraham M. de Vos1
or the receptors are promiscuous, EDA-A1 and EDA-A21Department of Protein Engineering
are thus far known to interact only with EDAR and2 Department of Molecular Oncology
XEDAR, respectively.Genentech, Inc.
The intracellular domains and signaling pathways of1 DNA Way
EDAR and XEDAR are also divergent, amplifying theSouth San Francisco, California 94080
switch between EDA-A1 and EDA-A2. EDAR possesses
an intracellular death domain which interacts with the
adaptor EDARDD, which in turn interacts with TRAFs 1,
Summary
2, and 3 (Headon et al., 2001; Yan et al., 2002). XEDAR
lacks a death domain and has been shown to signal via
EDA is a tumor necrosis factor family member involved TRAF-6 (Yan et al., 2000; Naito et al., 2002; Sinha et al.,
in ectodermal development. Splice variants EDA-A1 2002). Specific mutations in EDA, EDAR, EDARDD, and
and EDA-A2 differ only by the presence of Glu 308 and TRAF6 result in symptoms of hypohidrotic ectodermal
Val 309 in the expected receptor binding region of dysplasia (HED), which is characterized by defects in
EDA-A1 but not EDA-A2. This two amino acid differ- sweat glands, hair follicles, and teeth (Monreal et al.,
ence functions as a switch controlling receptor speci- 1998; Tucker et al., 2000; Headon et al., 2001; Naito et
ficity. EDA-A1 binds only to EDAR, while EDA-A2 is al., 2002). The biology of the EDA-A2/XEDAR pathway
specific for XEDAR. In order to understand the struc- is not as well characterized as that of EDA-A1/EDAR.
tural basis of this switch, we determined the X-ray Although EDA is one of the most divergent TNFLs,
crystal structures of the TNF domain of both EDA-A1 both XEDAR and EDAR are conventional TNFRs with
and EDA-A2 at 2.3 A˚ and 2.2 A˚, respectively. While the three cysteine-rich pseudorepeats (CRDs) in their extra-
backbone conformation around the splice difference cellular domains. Both receptors are missing the last of
is similar in both isoforms, the conformation of the the three canonical disulfide bridges in CRD3, and EDAR
following loop, the surface charge, and the shape of is missing an additional disulfide bridge in CRD2. How-
the expected receptor binding site differ significantly. ever, the remaining protein sequence of both EDAR and
XEDAR suggests that they are representative members
of the TNFR family with structural similarity to TNFR1.Introduction
Thus, each is expected to bind its cognate ligand in a
fashion similar to that seen in the crystal structures ofThe TNF families of ligands (TNFLs) and receptors
the LT/TNFR1 (Banner et al., 1993) and Apo2L (TRAIL)/(TNFRs) influence a variety of biological pathways, in-
DR5 (Hymowitz et al., 1999; Mongkolsapaya et al., 1999;cluding immune system regulation, apoptosis, and in-
Cha et al., 2000) complexes, in which the receptors makeflammation (Locksley et al., 2001). The distantly related
contacts along the monomer-monomer interfaces of theTNFL protein ectodysplasin (EDA) is involved in ectoder-
ligand. In particular, two CRDs from the receptor aremal development (Srivastava et al., 1997; Monreal et al.,
expected to contact ligand, with one of these domains1998; Baye´s et al., 1998; Tucker et al., 2000; Laurikkala
mediating contacts to the surface of the ligand in theet al., 2002; Mikkola and Thesleff, 2003). Like other TNFL
vicinity of the alternative splicing receptor specificityfamily members, EDA is a type II transmembrane protein
“switch.”with a C-terminal TNF domain. EDA also contains sev-
In order to better understand the relationship of EDAeral other structural features, including a furin site and
to other TNFLs, as well as how the two amino acida collagen-like sequence in the linker region between the
“switch” between EDA-A1 and EDA-A2 controls speci-transmembrane helix and the TNF domain (Schneider et
ficity for their respective receptors, we have determinedal., 2001; Wisniewski et al., 2002). The EDA gene tran-
the structure of the TNF domains of EDA-A1 and EDA-script is present in several splice forms (Srivastava et
A2. These structures show that the two amino acid dif-al., 1997; Monreal et al., 1998; Baye´s et al., 1998). Two of
ference between EDA-A1 and A2 dramatically influences
these splice forms contain all of the described features,
the shape and charge of approximately half of the ex-
differing only by a two amino acid motif, Glu 308 and
pected receptor binding interface. Interestingly, some
Val 309, which is present in EDA-A1 but not in EDA-A2 of the HED missense mutations in the TNF domain of
(Baye´s et al., 1998; Yan et al., 2000). Interestingly, this EDA are located in this region and thus might directly
difference is sufficient to confer absolute receptor speci- influence receptor binding.
ficity. EDA-A1 binds EDAR, a member of the TNFR family
involved in ectodermal development, while EDA-A2 Results and Discussion
binds to the related receptor, XEDAR (Baye´s et al., 1998;
Yan et al., 2000), which shares only 22% sequence iden- Overall Structure of EDA-A1 and EDA-A2
The 2.3 A˚ crystal structure of a fragment of EDA-A1
containing residues 233–391 was solved by molecular*Correspondence: hymowitz@gene.com
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Table 1. Data Collection and Refinement Statistics
EDA-A1 EDA-A2
Data Collection
Resolution (A˚) 30–2.30 (2.38–2.30)a 30–2.23 (2.40–2.23)a
Rsymb 0.081 (0.239)a 0.03 (0.079)a
Space group P21 P21
Unit cell (A˚) a  53.6, b  298, c  54.3 a  50.7, b 161, c  51.0
()   91.4   105
Number of observations 215,586 101,523
Unique reflections 66,596 37,259
Completeness (%) 94.4 (93.1)a 96.8 (93.1)a
Refinement
Resolution (A˚) 20–2.30 30–2.23
Number of reflections 66,278 37,223
Final Rc, Rfree (F  0) 0.195, 0.261 0.200, 0.241
Number of residues 1731 840
Number of solvent molecules 339 182
Number of non-H atoms 13896 6776
Rmsd bonds (A˚) 0.010 0.007
Rmsd angles () 1.28 1.16
Rmsd B (bonded atoms) (A˚2) 1.9 1.6
a Numbers in parentheses refer to the highest resolution shell.
b Rsym  |I  I|/I. I is the average intensity of symmetry related observations of a unique reflection.
c R  |Fo  Fc|/Fo. Rfree is calculated as R, but for 10% of the reflections excluded from all refinement and were chosen in thin resolution
shells due to noncrystallographic symmetry.
replacement and refined to an R and Rfree of 19.5% and
26.1%, respectively. The 2.2 A˚ structure of the same
fragment of EDA-A2 was also determined and refined
to an R and Rfree of 20.0% and 24.1% (Table 1). In both
isoforms, the EDA trimer resembles other TNFL family
members and is formed by three jelly-roll  sandwich
monomers. Each monomer is composed of two sheets
containing strands AAHCF and BBGDE. Systematically
shorter and generally well-ordered CD, EF, and DE loops
as well as the long but compactly folded AA loop make
the EDA trimer more globular and compact than other,
more pyramid-shaped TNFL family members (Figure 1).
Unlike either Apo2L/TRAIL (Hymowitz et al., 2000),
BAFF (Oren et al., 2002), or the structurally related NC1
domain of collagen X (Bogin et al., 2002), EDA shows
no evidence of metal binding. The surface of EDA-A1,
including the putative receptor binding region along the
monomer-monomer interface, is free of significant cavit-
ies or crevices. This surface is even flatter and less
charged in EDA-A2 (Figure 2). The lack of any substantial
surface features in either isoform is consistent with the
expected relatively large receptor interaction area with
dispersed binding determinants as previously observed
for the LT/TNFR1 (Banner et al., 1993) and Apo2L
(TRAIL)/DR5 (Hymowitz et al., 1999; Mongkolsapaya et
al., 1999; Cha et al., 2000) complexes.
Like BAFF, EDA was expected to contain a disulfide
bond linking strands E and F. Surprisingly, the predicted
disulfide bond between Cys 332 and Cys 346 is ob-
Figure 1. The Crystal Structure of EDAserved in the structure of EDA-A2 but not EDA-A1. The
(A) Walleyed stereo view of a ribbon rendering of the EDA-A1 trimer.absence of this disulfide bond in EDA-A1 is likely an
The trimer is oriented with its N and C termini at the top of the page.artifact resulting from protein production in the reducing
Individual monomers are colored in shades of pink.  strands andenvironment of the cytosol of E. coli and subsequent
relevant amino acids are labeled.
purification and storage at pH 6.5. EDA-A2 was ex- (B) Walleyed stereo view of the EDA-A2 trimer labeled as in (A).
pressed and purified in a similar fashion, but at a pH Individual monomers are colored in shades of blue.
more favorable for disulfide bond formation. Formation
Crystal Structures of EDA
1515
Figure 2. Electrostatic Surface of EDA-A1
(Left) and EDA-A2 (Right) and the Predicted
Receptor Binding Site
The molecular surface of both EDA isoforms
is colored according to the calculated elec-
trostatic surface potential with 	5 kT in blue,
neutral in white, and –5 kT in red. The pre-
dicted receptor binding surface is outlined in
yellow. The subdomain structure of XEDAR
and EDAR is depicted schematically with the
relative location and number of disulfide
bonds indicated by yellow lines. The N termini
of the receptors are at the top of the figure.
CRDs are labeled.
of this bond is expected in native EDA-A1 material and ies approximately 2000 A˚2. In this assembly, two of the
expected receptor binding sites are obscured, leavingwould only involve repositioning of the sulfur atom of
Cys 346 to the corresponding position in EDA-A2 with- four available. In the EDA-A1 crystals, two pairs of these
intimately associated trimers form the four-trimer asym-out any further changes to the structure.
metric unit, while in EDA-A2 one pair forms the asym-
metric unit. Despite the large interface, these dimers ofDimers of Trimers in the Asymmetric Units
trimers do not associate with high affinity in the absenceof EDA-A1 and EDA-A2
of the collagen-repeat region; size exclusion chromatog-The crystallographic asymmetric unit of both the EDA-
raphy of the TNF domain alone of both EDA-A1 andA1 and EDA-A2 crystals contains more than one copy
EDA-A2 indicates that both proteins exist as trimers atof the biologically relevant trimer. There are four trimers
0.2 mM (data not shown). Other than this dimer of tri-comprised of a total of 12 protomers in the EDA-A1
mers, the remaining crystal packing contacts are notasymmetric unit and two trimers or six protomers in the
unusual and show no indication of formation of higherEDA-A2 asymmetric unit. This extensive noncrystallo-
order assemblies such as those seen in some of thegraphic symmetry provides additional packing-indepen-
BAFF crystal forms (Liu et al., 2002, 2003; Kim et al.,dent information about the EDA structure. The 12 copies
2003).of the EDA-A1 protomer have an average root mean
Nevertheless, for full activity, soluble EDA trimerssquare deviation (rmsd) of 0.34 A˚ from the mean coordi-
need to be oligomerized into higher-order assembliesnates using C
 atoms for residues 248–388. The only
via the collagen-like region in the EDA stalk. Mutationssignificant variation among the 12 protomers occurs at
in this region reduce EDA activity (Baye´s et al., 1998;the beginning of the AA loop and at the tips of the
Schneider et al., 2001). It is not known if the collagen-likeCD and EF loops. The most striking difference is the
regions are solely responsible for the oligomerization orconformation of strand A in monomer J, which differs
if the TNF domains of EDA also interact. Ligation ofsignificantly from that of the other monomers, likely due
trimers into higher-order assemblies may increase re-to crystal packing. The asymmetric unit of EDA-A2
ceptor affinity by avidity, may change the geometry ofshows a greater degree of conformational variability, as
the ligand-receptor complex, or may be required in orderreflected by a higher rmsd of 0.80 A˚ from the mean
to recruit adaptor proteins to the intracellular domainscoordinates using C
 atoms of residues 248 to 389. In
of the receptors. While constructs of EDA-A1 and EDA-particular, the AA and EF loops show more divergence
A2 lacking the collagen-like region pack in the crystalsthan in the EDA-A1 structure. However, in the area of
as dimers of trimers, the physiological importance, ifthe receptor specificity switch, all copies of both EDA-
any, of this interface is unclear.A1 and EDA-A2 agree well within each isoform but differ
considerably between isoforms.
Even though the EDA-A1 asymmetric unit contains The Structure of the EDA-A1 Receptor
Specificity Switchfour trimers while the EDA-A2 asymmetric unit is com-
posed of two trimers, the crystal packing within the unit In EDA-A1, the receptor specificity switch (residues Glu
308 and Val 309) forms the C-terminal portion of strandcells is similar. The similarity of the crystal packing is
due to in part to the presence of an almost identical C and is followed by a  bulge created by residues Tyr
310 and Tyr 311, which in turn are connected to a six-“dimer of trimers” in the asymmetric unit of both crystals.
In both cases, the trimers are oriented parallel to one residue loop that leads to strand D. Glu 308 and Val 309
are part of a  strand (Figures 1A and 3A) and makeanother such that their termini are on the same side.
The interface between the trimers is formed by one many interactions with the adjacent GH loop and strand
F. In particular, the side chain conformation of Glu 308monomer-monomer interface from each trimer and bur-
Structure
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Figure 3. Details of the Receptor Specificity
Switch
(A) EDA-A1 Glu 308 is tightly positioned. Resi-
dues surrounding Glu 308 are shown. The 
strands formed by the backbone are repre-
sented as arrows. Side chains have been
omitted from most residues for clarity. Hydro-
gen bonds are indicated by dashed lines.
(B) EDA-A2 residues surrounding Tyr 310.
(C) Walleyed stereo view of a superposition
of the specificity switch regions of EDA-A1
(pink) and EDA-A2 (blue). Selected EDA-A2
residues are labeled in black. Where the EDA-
A1 and EDA-A2 structures differ consider-
ably, EDA-A1 residues are labeled in pink.
is reinforced by hydrogen bonds to Thr 333 in strand E TNF, and LT. This observation led to the prediction that
Glu 308 and Val 309 would be accommodated as aof the neighboring monomer as well as to Asn 372 and
Thr 377 in the adjacent GH loop. Val 309 packs in the two-amino acid  bulge. In contrast, the experimental
structure shows that Glu 308 and Val 309 are an integralhydrophobic core of the monomer. The next two resi-
dues, Tyr 310 and Tyr 311, form an antiparallel classical part of the C strand forming regular antiparallel  sheet
hydrogen bonding, while Tyr 310 and Tyr 311 form a bulge (Chan et al., 1993) with Ser 370, which is part
of a partial strand in the GH loop. These two residues classical antiparallel  bulge (Figures 1 and 3A).
are followed by irregular extended structure until residue
Phe 314, where a turn from Phe 314 to Phe 317 connects Receptor Specificity Switch in EDA-A2
In EDA-A2, the C strand is the same length as in EDA-to strand D. This turn is well ordered in some copies
and poorly ordered in others and is a site of deviation A1, but due to alternative splicing of the mRNA, different
residues compose the C-terminal end of this strand. Thefrom the noncrystallographic symmetry. Asn 313 is gly-
cosylated when EDA is expressed in mammalian cells main chain atoms of Tyr 310 and Tyr 311 occupy the
same spatial position as those of Glu 308 and Val 309(Schneider et al., 2001). This residue is at the tip of the
CD loop, and the glycosyl-modified side chain is not in EDA-A1. However, the side chain of Tyr 310 makes
very different interactions than are seen for Glu 308. Inlikely to significantly influence either receptor binding
or ligand structure. particular, it does not form any of the hydrogen bonds
seen in the EDA-A1 structure. Concomitantly, the sideContrary to assumptions based on sequence analysis
and construction of a homology model of EDA-A1 (Yan chains of Thr 333 and Tyr 343 are in a different position
than in EDA-A1. However, the conformation of the GHet al., 2000), Glu 308 and Val 309 do not insert into strand
C by forming a  bulge. The inadequacy of the homology loop is essentially identical in both isoforms (Figures 1
and 3).model derives mostly from incorrect assumptions about
the sequence alignment. In particular, Tyr 310 and Tyr In the structure of EDA-A2, the  bulge following the
C strand is also intact but involves different residues311 were expected to align with hydrophobic residues
at the end of the C strand as seen in Apo2L (TRAIL), than in EDA-A1 and is formed by Ile 312, Asn 313, and
Crystal Structures of EDA
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Ser 370 in all six copies of the EDA-A2 protomer. Both
the main chain and side chain conformation of the CD
loop differ considerably between the two isoforms. In
EDA-A2, Ile 312 is exposed at the surface of the ex-
pected receptor binding site and the side chain of Phe
314 is completely buried, while in EDA-A1, Ile 312 is
buried and Phe 314 is exposed. The CD loop is also
two residues shorter, which is accommodated by the
movement of residues 314 and 315 (Figures 1 and 3).
Propagation of insertions or deletions in secondary
structure to subsequent loops is not unprecedented and
has been seen in the T4 lysozyme model system, where
addition of several residues to a helix resulted in reregis-
tering of the helix and lengthening of the following loop
rather than an interruption of the helix (Heinz et al., 1993).
In EDA, the conformational adaptability of the CD loop Figure 4. Functional Redundancy of CRD1 and CRD2 of EDAR and
XEDARbetween isoforms is not surprising, as this loop does
Schematic depiction of the receptor chimeras and their observednot seem to be well packed in the EDA-A1 structure as
ligand specificity.reflected by higher temperature factors and greater NCS
deviations than in the rest of the ligand. Altered packing
of the CD loop in EDA-A2 causes a shift of the main chain
determinants reside in CRD3 of XEDAR. By analogy,of the EF loop by up to 6 A˚, although the conformation of
CRD3 of EDAR is expected to be required for recognitionthis loop is generally similar to that seen in the EDA-A1
of EDA-A1. The reverse chimera composed of CRD1structure.
and CRD2 of XEDAR with CRD3 of EDAR did not bind
either EDA-A1 or EDA-A2, suggesting that CRD3 from
Differences between EDA-A1 and EDA-A2 in the EDAR is not structurally compatible with CRD1 and
Expected Receptor Binding Site CRD2 from XEDAR. This incompatibility prevents experi-
EDA-A2 differs from EDA-A1 only by the absence of Glu mental confirmation of the EDAR binding determinants
308 and Val 309. This variation causes considerable for EDA-A1.
alteration to the surface of the protein due to different These data are also consistent with the structures of
chemical properties, shape, and orientation of the side LT with TNFR1 and Apo2L (TRAIL) with DR5, in which
chains at the expected receptor binding site. In particu- CRD3 of the receptors contacts the ligand surface in
lar, the differences in both shape and chemical charac- the region corresponding to the EDA specificity switch.
teristics between the Glu (EDA-A1) and Tyr (EDA-A2) In contrast, the surfaces of EDA with which CRD2 is
moieties have two significant effects. First, loss of the predicted to interact are essentially the same in both
negative charge drastically changes the electrostatic isoforms (Figure 2). Thus, any contacts made by CRD2
characteristics of the ligand surface. EDA-A1 has a re- from EDAR and XEDAR with the ligand should be func-
gion of negative surface charge at the center of the tionally redundant; i.e., the specificity of a receptor hy-
expected receptor binding site, while the surface of brid will correlate with the identity of CRD3 as shown
EDA-A2 is largely neutral in this area (Figure 2). Second, by the chimera data.
the receptor binding surface is even flatter and more In order to further understand the receptor specificity
featureless in EDA-A2 than in EDA-A1 due to rearrange- switch, homology models of EDAR and XEDAR were
ment of the residues forming the binding site, including made using the structure of TNFR1 as a template. The
the reorientation of Tyr 343, and the presence of Tyr models of the receptors were docked onto the struc-
310 and Ile 312 at the center of the site (Figure 3). The tures of EDA-A1 and EDA-A2, and are in agreement
altered positions of these amino acids result in differ- with the chimera data as they also indicate that CRD3
ences in the surface characteristics between EDA-A1 interacts with the receptor specificity switch. The low
and EDA-A2 that are sufficient to determine receptor level of sequence identity between either EDAR or
specificity. XEDAR to TNFR1 as well as the lack of regular secondary
structure and the nonglobular fold of the TNF receptors
severely limits the accuracy of these homology modelsReceptor Chimeras Indicate that CRD3
and prevents more detailed analysis of receptor-ligandDetermines Specificity
interactions. Determination of cocrystal structures ofIn order to determine which portions of the receptors
either EDA-A1 with EDAR or EDA-A2 with XEDAR willare responsible for ligand specificity, several chimeras
be required for elucidation of the atomic details of thebetween EDAR and XEDAR were made and assayed
specificity determinants of the receptors.for binding with limited success (Figure 4). Chimeras in
which either CRD1 alone or both CRD1 and CRD2 of
XEDAR were replaced with the corresponding domains Location of Mutations That Cause HED
Mutations in EDA, EDAR, and EDARDD can cause HEDfrom EDAR retained specificity for EDA-A2. These data
indicate that CRD1 and CRD2 of XEDAR are not required (Monreal et al., 1998; Tucker et al., 2000; Schneider et
al., 2001; Headon et al., 2001; Yan et al., 2002). Whilefor discrimination between EDA-A1 and EDA-A2. In-
stead, these experiments indicate that ligand specificity many of the alterations affecting EDA involve either
Structure
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Tyr 343 and Ser 374, are also buried in the interface
formed by the dimer of trimers in the crystallographic
asymmetric unit.
In the final group, the seemingly innocuous point mu-
tations of Asp298His, Ala356Asp, and Arg357Pro, as
well as the variant Gly299Ser, are clustered together at
the surface of the protein, suggesting that they might
form an additional binding site (Figure 5). However, since
this area of the ligand surface is not expected to form
part of the canonical receptor binding site, nor is it in-
volved in the crystal packing contact forming the dimer
of trimers, the function of this site is unknown. It is also
possible that some of these mutations may deleteriously
affect the ligand by altering its solution or folding proper-
ties. This is supported by the observation that recombi-
nant EDA-A1 and A2 carrying the Ala356Asp mutation
are not properly secreted by mammalian cells (Schnei-
der et al., 2001).
Conclusions
Proteins evolve and achieve specificity in diverse ways.
Figure 5. Locations of HED Mutations The relationship between EDA-A1 and EDA-A2 is an
The EDA-A1 trimer is shown as a ribbon rendering in white with elegant example of evolution at work. Two almost identi-
relevant side chains rendered in spheres. The carbon atoms of muta- cal proteins, whose differences are due to alternative
tions likely to affect overall ligand structure are colored yellow, muta-
splicing of the same gene, interact specifically with twotions near Glu 308 are colored cyan, and mutations forming a distinct
very divergent receptors. The two amino acid differencesurface patch are colored pink.
between EDA-A1 and EDA-A2 has considerable effects
on the electrostatics and shape of the protein surfaces
in the vicinity of the receptor binding site. These differ-
frameshifts or gene truncations with concomitant alter-
ences determine receptor specificity and form the basis
ations in, or the absolute absence of, the EDA message,
of a receptor specificity switch. The structures of the
missense mutations have also been described which
EDA-A1 and EDA-A2 isoforms, the effects of naturally
result in a single point mutation in the EDA protein. Many
occurring, disease-causing mutations in the TNF do-
of these mutations have recently been cataloged and
main, and characterization of chimeric receptors all sup-
mapped to the appropriate domains of the mature pro-
port this conclusion. The disparity in conservation be-
tein (Schneider et al., 2001). Determination of the struc-
tween EDAR and XEDAR versus EDA-A1 and EDA-A2
ture of the TNFL domain of EDA permits dissection of the
suggests that the evolutionary histories of the EDA iso-
molecular details of the mutations affecting this domain
forms and their receptors may be very different. The
(Figure 5).
recent discovery of two receptors, TROY and RELT (Eby
The HED-causing mutations that affect the TNFL do-
et al., 2000; Kojima et al., 2000; Sica et al., 2001), with
main of EDA can be divided into three classes: mutations
significant homology to EDAR and XEDAR, respectively,
which likely affect the overall structure of EDA, muta-
but without known ligands, suggests that other ligands,
tions which affect the receptor binding site, and muta-
or possibly additional EDA splice variants, might exist
tions whose effect is uncertain but which may define a
which interact with these receptors and could potentially
novel interaction site. In the first group, the individual
crossreact with EDAR or XEDAR.
mutations His252Leu, Gly291Trp, Gly291Arg, Gly299Ser,
Tyr320Cys, or Ala349Asp probably globally destabilize
Experimental Proceduresthe ligand (Figure 5). All of these mutations either replace
small amino acids with larger residues that cannot be Protein Expression, Purification, and Crystallization
accommodated structurally, or replace large amino A gene optimized for expression of EDA-A1 in E. coli was purchased
from Aptagen, Inc. (Herndon, VA), in order to overcome the very lowacids in the core of the protein with residues that cannot
expression levels found in E. coli for the natural human sequence.make the same packing interactions.
DNA encoding EDA-A1 residues 233–391 was subcloned into theIn the second class, the HED-causing point mutations
pET15b vector and then transformed into BL-21 (DE3) cells carryingTyr343Cys, Ser374Arg, Thr378Pro, or Thr378Met are all
pLysS. Cells were grown at 37C until mid-log phase in LB medium
located adjacent to the receptor specificity switch and with 50 mg/ml carbenicillin, then cooled to 16C prior to induction
are predicted, based on the structures presented here, with 1 mM IPTG. 50 g of fermentation cell paste was resuspended
in 50 mM Tris (pH 8), 500 mM NaCl, and 10 mM imidazole and lysedto either form (Tyr 343, Ser 374) or buttress (Thr 378)
by passage through a microfluidizer. The soluble fraction was loadedparts of the receptor binding site. The mutation of Tyr
onto a Ni-NTA agarose column and eluted with a step gradient of343 to Cys is of particular interest, since this residue
275 mM imidazole. The EDA-A1-containing fractions were pooled,is in a different conformation in the EDA-A1 and A2
1 unit of thrombin was added per mg of fusion protein, and the
structures. Furthermore, recombinant EDA-A1 containing solution was dialyzed overnight at 4C against 20 mM Tris (pH 7)
this mutation is trimeric and soluble, but does not bind and 1 mM CaCl2. The dialysate was loaded on a monoS column
pre-equilibrated in 20 mM Bis-Tris (pH 6.5); EDA-A1 was eluted withEDAR (Schneider et al., 2001). Two of these residues,
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a 0 to 1 M NaCl gradient. The fractions containing EDA-A1 were of the 1731 ordered residues are in the most favored, additionally
allowed, generously allowed, and disallowed regions of the Rama-further purified on a S-200 size exclusion column equilibrated in 20
mM Bis-Tris (pH 6.5) and 200 mM NaCl. Fractions corresponding chandran plot, respectively. For EDA-A2, 83.1%, 15.2%, 1.1%, and
0.7% of the 840 ordered residues are in the most favored, addition-to trimeric protein were pooled. Final yield was 15 mg purified protein
per 50 g of cell paste. ally allowed, generously allowed, and disallowed regions, respec-
tively.The purified protein was concentrated to 8.5 mg/ml and used for
crystallization trials. After several weeks at 19C, EDA-A1 crystal- Secondary structure and bulge assignment was analyzed with
PROMOTIF. Figures were prepared with Molscript (Kraulis, 1991),lized as thin plates in 4 l hanging drops consisting of 2 l protein
and 2 l well solution over a well solution of 20% PEG 3350 and Render 3D (Merrit and Murphy, 1994), and pymol (Delano Com-
puting).0.2 M di-sodium hydrogen phosphate. The crystals were immersed
in a solution of 18% PEG 3350, 0.16 M di-sodium hydrogen phos-
phate, and 20% PEG 300 prior to cryocooling by immersion in liquid Acknowledgments
nitrogen.
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